ArticleScientific reports2017

BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.

Hye Rim Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.